{"id":"NCT01355627","sponsor":"Takeda","briefTitle":"TASALL - TachoSil® Against Liquor Leak","officialTitle":"TachoSil® Versus Current Practice in Dura Sealing Techniques for the Prevention of Post-operative Cerebrospinal Fluid (CSF) Leaks in Patients Undergoing Skull Base Surgery: An Open Label, Randomised, Controlled, Multi-centre, Parallel Group Efficacy and Safety Trial.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2013-06","completion":"2013-06","firstPosted":"2011-05-18","resultsPosted":"2014-07-25","lastUpdate":"2014-07-25"},"enrollment":726,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cerebrospinal Fluid Leaks"],"interventions":[{"type":"PROCEDURE","name":"TachoSil®","otherNames":[]},{"type":"PROCEDURE","name":"Current Practice","otherNames":[]}],"arms":[{"label":"TachoSil®","type":"EXPERIMENTAL"},{"label":"Current practice group","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective is to demonstrate superiority of TachoSil® compared to current practice as an adjunct in sealing the dura mater. The efficacy of the dura mater sealing must be evaluated post-operatively. The secondary objective is to evaluate the safety of TachoSil® as an adjunct in sealing the dura mater.\n\nThe trial population will consist of 726 randomised (1:1) patients elected for skull base surgery. The trial duration consists of screening, surgery, efficacy follow-up after 7±1 weeks and safety follow-up 28±2 weeks after surgery.","primaryOutcome":{"measure":"Percentage of Participants With Clinically Evident Verified Post-Operative Cerebrospinal Fluid Leak or Clinically Evident Pseudomeningocele or Treatment Failure","timeFrame":"Up to 8 Weeks (7 Weeks ± 1 Week)","effectByArm":[{"arm":"TachoSil®","deltaMin":6.9,"sd":null},{"arm":"Current Practice Group","deltaMin":8.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.485"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":39,"countries":["Austria","Belgium","France","Germany","Greece","Italy","Netherlands","Poland","Russia","Spain","Sweden"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":94,"n":362},"commonTop":["Pneumocephalus","Hypokalaemia","Hypertension","Constipation","Pyrexia"]}}